PMID- 28463977 OWN - NLM STAT- MEDLINE DCOM- 20170905 LR - 20190208 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 5 DP - 2017 TI - Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection. PG - e0176641 LID - 10.1371/journal.pone.0176641 [doi] LID - e0176641 AB - Dysfunction of T follicular-helper (TFH) cells is a possible cause of impaired germinal centre (GC) and IgG antibody responses in individuals with human immunodeficiency virus-1 (HIV-1) infection and might contribute to decreased magnitude and isotype diversification of IgG antibodies to pneumococcal polysaccharides (PcPs). We examined the production of IgG1 and IgG2 antibodies to PcPs 4, 6B, 9V and 14 by enumerating antibody secreting cells (ASCs) at day (D) 7 and determining fold-increase in serum antibody levels at D28 after vaccination with unconjugated PcPs in HIV seronegative subjects (n = 20) and in HIV patients who were receiving antiretroviral therapy (ART) (n = 28) or who were ART-naive (n = 11) and determined their association with ICOS+ and ICOS- circulating memory TFH (cmTFH) cells (CD4+CD45RA-CD27+CXCR5+PD-1+) and short lived plasmablasts (SPBs) at D7, and with PcP-specific and total IgM+ and IgG+ memory B cells at D0. In HIV seronegative subjects, production of IgG1+ and IgG2+ ASCs was consistently associated with the frequency of ICOS+ cmTFH cells but not ICOS- cmTFH cells or memory B cells. In contrast, post-vaccination ASCs in HIV patients, regardless of ART status, were lower than in HIV seronegative subjects and not associated with ICOS+ cmTFH cells, the expansion of which was absent (ART-naive patients) or much lower than in HIV seronegative subjects (ART-treated patients). Production of SPBs was also lower in ART-naive patients. Fold-increase in IgG2 antibodies at D28 also correlated with ICOS+ cmTFH cells at D7 in HIV seronegative subjects but not in HIV patients. These novel findings provide evidence that ICOS+ cmTFH cells contribute to the regulation of PcP-specific IgG antibody responses, including isotype diversification, and that TFH cell dysfunction may be a cause of impaired PcP-specific IgG antibody responses and increased susceptibility to pneumococcal disease in HIV patients. FAU - Abudulai, Laila N AU - Abudulai LN AD - School of Pathology & Laboratory Medicine, The University of Western Australia, Perth, Australia. FAU - Fernandez, Sonia AU - Fernandez S AUID- ORCID: 0000-0001-8753-466X AD - School of Pathology & Laboratory Medicine, The University of Western Australia, Perth, Australia. FAU - Corscadden, Karli AU - Corscadden K AD - Center for Vaccine and Infectious Disease Research, Telethon Kids Institute, The University of Western Australia, Perth, Australia. FAU - Burrows, Sally A AU - Burrows SA AUID- ORCID: 0000-0002-8499-4537 AD - School of Medicine & Pharmacology, The University of Western Australia, Perth, Australia. FAU - Hunter, Michael AU - Hunter M AD - Department of Infectious Diseases, Prince of Wales Hospital, Sydney, Australia. AD - Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. FAU - Tjiam, M Christian AU - Tjiam MC AD - School of Pathology & Laboratory Medicine, The University of Western Australia, Perth, Australia. FAU - Kirkham, Lea-Ann S AU - Kirkham LS AD - Center for Vaccine and Infectious Disease Research, Telethon Kids Institute, The University of Western Australia, Perth, Australia. AD - School of Paediatrics and Child Health, The University of Western Australia, Perth, Australia. FAU - Post, Jeffrey J AU - Post JJ AD - Department of Infectious Diseases, Prince of Wales Hospital, Sydney, Australia. AD - Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. FAU - French, Martyn A AU - French MA AD - School of Pathology & Laboratory Medicine, The University of Western Australia, Perth, Australia. AD - Department of Clinical Immunology, Royal Perth Hospital and PathWest Laboratory Medicine, Perth, Australia. LA - eng PT - Journal Article DEP - 20170502 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Anti-HIV Agents) RN - 0 (ICOS protein, human) RN - 0 (Immunoglobulin G) RN - 0 (Inducible T-Cell Co-Stimulator Protein) RN - 0 (Pneumococcal Vaccines) RN - 0 (Polysaccharides, Bacterial) SB - IM MH - Anti-HIV Agents/therapeutic use MH - Antibody Formation/immunology MH - HIV Infections/drug therapy/*immunology MH - Humans MH - Immunoglobulin G/*immunology MH - Inducible T-Cell Co-Stimulator Protein/*immunology MH - Pneumococcal Infections/*immunology MH - Pneumococcal Vaccines/immunology MH - Polysaccharides, Bacterial/*immunology MH - T-Lymphocytes, Helper-Inducer/immunology PMC - PMC5413043 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2017/05/04 06:00 MHDA- 2017/09/07 06:00 PMCR- 2017/05/02 CRDT- 2017/05/03 06:00 PHST- 2017/03/29 00:00 [received] PHST- 2017/04/13 00:00 [accepted] PHST- 2017/05/03 06:00 [entrez] PHST- 2017/05/04 06:00 [pubmed] PHST- 2017/09/07 06:00 [medline] PHST- 2017/05/02 00:00 [pmc-release] AID - PONE-D-17-10373 [pii] AID - 10.1371/journal.pone.0176641 [doi] PST - epublish SO - PLoS One. 2017 May 2;12(5):e0176641. doi: 10.1371/journal.pone.0176641. eCollection 2017.